Therapeutic Research Protocol Dose: 2 mg Tesamorelin + 300 mcg Ipamorelin Duration: 12 16 weeks Frequency: Daily, evening administration Cycle Interval: 6 8 weeks off before repeating Goal / Description: Higher-dose protocol for visceral fat reduction and IGF-1 elevation studies
Vaccine 33:61736177 Malaguarnera M, Gargante MP, Cristaldi E, Colonna V, Messano M, Koverech A, Neri S, Vacante M, Cammalleri L, Motta M (2008) Acetyl l-carnitine (ALC) treatment in elderly patients with fatigue
This severe metabolic inflexibility directly contributes to the debilitating phenomenon of post-exertional malaise (PEM), where patients experience a massive, multi-day crash in symptoms following minor physical or cognitive exertion, effectively trapping them in a cycle of energy debt
Cerqueira, D
Match Your Peptides to Your Personal Goals Peptide therapy is not a one-size-fits-all solution